Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0801-2025Class II

Dialyzer Optiflux 160NRe

Fresenius Medical Care Renal Therapies Group, LLC / initiated 2024-12-05 / Open, Classified / root cause: manufacturing process

Fresenius Medical Care Holdings, Inc. began a recall of Dialyzer Optiflux 160NRe on . FDA classified it as Class II and gives the reason as "Potential for internal blood leaks due to cracked polyurethane". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0801-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Fresenius Medical Care Renal Therapies Group, LLC
Product
Dialyzer Optiflux 160NRe
Product code
KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System
Reason for recall
Potential for internal blood leaks due to cracked polyurethane
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Fresenius Medical Care notified consignees on about 12/05/2024 via URGENT MEDICAL DEVICE RECALL letter. Consignees were instructed to stock immediately for either of the affected lot numbers, immediately discontinue use of Optiflux F160NRe Dialyzer(s) with lot codes, place any of the affected units in a secure, segregated area, arrange for return of affected product and complete and return the provided Reply Form. Additionally, consignees were instructed to forward the notification to any personnel within the organization or to customers where product was further distributed.
Quantity in commerce
5,351 cases (64,212 dialyzers)
Distribution
Nationwide Distribution.
Product codes and lots
UDI NUMBERS: 24HU06011-00840861100149-270630, 24HU06010-00840861100149-270630. Expiration date: 06/30/2027.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0801-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0801-2025Class IIOngoingVoluntary: Firm initiated